Asia Cervical Cancer Test Market (1)

About This Presentation
Title:

Asia Cervical Cancer Test Market (1)

Description:

Cervical cancer is one of the most common cancer among the women in Asian region. More than 280 Thousand new cases diagnosed each year and due to non preventive action taken timely, every year cervical cancer related death has cross over 140 Thousand. Testing is the best way to prevent and cure the disease. In the Asian region most common preventive cervical cancer methods are: Pap smear test, HPV DNA Test and VIA test. Our Report title “Cervical Cancer Test Market & Patients (Pap Smear HPV DNA VIA) Asia (Japan, Korea, Singapore, Malaysia, India, China, Thailand, Indonesia)” For More Information: – PowerPoint PPT presentation

Number of Views:9

less

Transcript and Presenter's Notes

Title: Asia Cervical Cancer Test Market (1)


1
Cervical Cancer Test Market Analyst View
Cervical cancer is one of the most common cancer
among the women in Asian region. More than 280
Thousand new cases diagnosed each year and due to
non preventive action taken timely, every year
cervical cancer related death has cross over 140
Thousand.   Press Release Title Asia Cervical
Cancer Test Market Growth Opportunity in VIA Test
Market Pap Smear Test Market   For More
Information http//www.renub.com/asia-cervical-ca
ncer-test-market-growth-opportunity-in-via-test-ma
rket-and-pap-smear-test-22-nd.php

2
Asia Cervical Cancer Test Market Growth
Opportunity in VIA Test Market Pap Smear Test
Market
Download Full Report http//www.renub.com/cervic
al-cancer-test-market-and-patients-pap-smear-hpv-d
na-via-asia-japan-korea-singapore-malaysia-india-c
hina-thailand-indonesia-985-p.php
Cervical cancer is one of the most common cancer
among the women in Asian region. More than 280
Thousand new cases diagnosed each year and due to
non preventive action taken timely, every year
cervical cancer related death has cross over 140
Thousand. Testing is the best way to prevent and
cure the disease. In the Asian region most common
preventive cervical cancer methods are Pap
smear test, HPV DNA Test and VIA test. Our Report
title Cervical Cancer Test Market Patients
(Pap Smear HPV DNA VIA) Asia (Japan, Korea,
Singapore, Malaysia, India, China, Thailand,
Indonesia) provides details of the following
points Asia Cervical Cancer Testing Population
(Pap, HPV DNA, VIA) Asia Cervical Cancer Testing
Market ((Pap, HPV DNA, VIA) Asia Cervical Cancer
Mortality Population Asian Countries (Japan,
Korea, Singapore, Malaysia, India, China,
Thailand, Indonesia)

3
Asia Cervical Cancer Test Market Growth
Opportunity in VIA Test Market Pap Smear Test
Market
Japan is playing the leading role in Asia
Cervical Cancer Pap Smear Test Market Pap smear
is commonly known Pap test, is an exam a doctor
uses to test for cervical cancer in women. A Pap
smear is a microscopic examination of cells taken
from the uterine cervix. A Pap smear can detect
human papillomavirus (HPV), which is main cause
of cervical cancer. Early treatment of
precancerous changes detected on the Pap smear
can stop cervical cancer before it fully
develops. The primary healthcare in Japan
performs well in managing people suffering from
chronic diseases and preventing unnecessary
hospitalizations. In 2013, cervical cancer
screening rate in Japan has grown to 42.1 percent
of the women population age group between 20-69
years, form 23.7 percent in 2003. HPV DNA Test
market is the 2nd Largest Market in Asia Human
papillomavirus (HPV) infection is now a
well-established cause of cervical cancer. HPV
types 16 and 18 are responsible for about 70 of
all cervical cancer cases. HPV vaccines that
prevent HPV 16 and 18 infections are now
available and have the potential to reduce the
incidence of cervical.

4
Asia Cervical Cancer Test Market Growth
Opportunity in VIA Test Market Pap Smear Test
Market
It is anticipated that Asia has 1.63 Billion
women population aged 15 years and older who are
at risk of developing cervical cancer. As a
result, HPV DNA test market has good potential to
grow in the region.
VIA Test Market is in novice stage and mainly
used in Middle and Low Income Countries VIA test
market is in novice stage and mainly used in
middle and low income countries such as India,
China, Thailand, Indonesia etc. VIA test is
popular in Asian region due to its low testing
cost and its immediate result. The main
advantage of VIA test is that it can perform on
primary healthcare center. It does not require
complicated equipment and can be done by trained
health workers.
5
Asia Cervical Cancer Test Market Growth
Opportunity in VIA Test Market Pap Smear Test
Market
Medical Devices Report http//www.renub.com/medi
cal-devices-15-c.php
  • Renub Research - North America
  • Rajat Gupta
  • 225 Kristie Ln, Roswell
  • Georgia 30076, United States
  • Tel 1-678-302-0700
  • Email info_at_renub.com
  • www.renub.com
  •  
  • Renub Research - Asia
  • Ankit Mishra
  • C 86, Sector 10
  • Noida 201301, India
  • Tel 91-120-421-9822
  • Email info_at_renub.com
Write a Comment
User Comments (0)